Artificial Intelligence-assisted Insulin System in Type 2 Diabetes in General Wards
NCT ID: NCT06319300
Last Updated: 2025-08-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
140 participants
INTERVENTIONAL
2024-04-19
2026-05-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Insulin Dose Calculation Software in Insulin Therapy
NCT05389839
Artificial Intelligence Assisted Insulin Titration System
NCT04053959
Study to Assess the Efficacy and Safety of iNCDSS in Type 2 Diabetes Mellitus Patients
NCT04642378
Insulin Titration System Based on Deep Learning
NCT05409391
Explainable Insulin Decision-making System to Assist Physicians in Diabetes Management
NCT06434584
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AI group
AI-assisted insulin dosage adjustment
AI-assisted insulin dose adjustment model
We use an artificial intelligence-assisted insulin dose adjustment system to adjust insulin doses in hospitalised patients
Doctor group
doctor adjust insulin
doctor's insulin dose adjustment
participants' insulin doses are adjusted by doctors
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
AI-assisted insulin dose adjustment model
We use an artificial intelligence-assisted insulin dose adjustment system to adjust insulin doses in hospitalised patients
doctor's insulin dose adjustment
participants' insulin doses are adjusted by doctors
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age≥18 years old
* Receiving glucose-lowering therapy for at least 90 days
* Blood glucose:7.8-22.2 mmol/L
* Length of proposed hospitalisation ≥5 days
Exclusion Criteria
* BG\>22.2 mmol/L, or acute complications of diabetes, such as diabetic ketoacidosis, diabetic hyperosmolar state.
* History of severe or repeated hypoglycaemia
* BMI≥45 kg/m2
* Pregnant and lactating women
* Clinically relevant liver disease (established cirrhosis and portal hypertension);
* Presence of severe renal disease (serum creatinine ≥3.0 mg/dL or estimated glomerular filtration rate \<30 ml/min/1.73 m2);
* Severe cardiac insufficiency;
* Patients on cortisol-based hormone therapy (equivalent to a prednisone dose \>5 mg/day);
* Psychiatric abnormalities or impaired cognitive function;
* Patients with severe oedema, infection, or peripheral blood circulation disorder;
* Patients with severe illness or patients to be transferred to ICU for treatment;
* Surgery of the heart or abdomen that may have a significant impact on the test is planned during hospitalisation.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai Fifth People's Hospital
UNKNOWN
Shanghai Zhongshan Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zhongshan Hospital, Fudan University
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20240115023245436
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.